In the article “Tumor Uptake of 64Cu-DOTA-Trastuzumab in Patients with Metastatic Breast Cancer” by Mortimer et al. (J Nucl Med. 2018;59:38–43), data in the HER2– column of Table 1 were left out because of a copyediting error. The corrected table appears below. We regret the error.
View this table:
TABLE 1
Patient Demographics and Clinical Characteristics
- © 2018 by the Society of Nuclear Medicine and Molecular Imaging.
